U.K. advises under-40s get alternative to AstraZeneca jab
The Hindu
The Joint Committee on Vaccination and Immunisation said it was taking the "precautionary approach" for adults aged 30-39, after assessment of blood clot risks
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab. The Joint Committee on Vaccination and Immunisation (JCVI) said it was taking the "precautionary approach" for adults aged 30-39, after assessment of. Professor Wei Shen Lim of the JCVI advisory committee said that those aged 30-39 will be "preferentially offered an alternative to the AstraZeneca vaccine".More Related News